Seroatlas · Human Serome Atlas

CD2

T-cell surface antigen CD2

Also known as: CD2_HUMAN, SRBC

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P06729
Gene
CD2
Ensembl
ENSG00000116824
Chromosome
1
Canonical length
351 aa
Protein class
CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Nucleoplasm,Golgi apparatus,Plasma membrane

OverviewNCBI Gene

The protein encoded by this gene is a surface antigen found on all peripheral blood T-cells. The encoded protein interacts with LFA3 (CD58) on antigen presenting cells to optimize immune recognition. A locus control region (LCR) has been found in the 3' flanking sequence of this gene. [provided by RefSeq, Jun 2016]

Canonical amino-acid sequenceUniProt

351 residues, UniProt reviewed canonical sequence.

>P06729|CD2
     1  MSFPCKFVAS FLLIFNVSSK GAVSKEITNA LETWGALGQD INLDIPSFQM SDDIDDIKWE
    61  KTSDKKKIAQ FRKEKETFKE KDTYKLFKNG TLKIKHLKTD DQDIYKVSIY DTKGKNVLEK
   121  IFDLKIQERV SKPKISWTCI NTTLTCEVMN GTDPELNLYQ DGKHLKLSQR VITHKWTTSL
   181  SAKFKCTAGN KVSKESSVEP VSCPEKGLDI YLIIGICGGG SLLMVFVALL VFYITKRKKQ
   241  RSRRNDEELE TRAHRVATEE RGRKPHQIPA STPQNPATSQ HPPPPPGHRS QAPSHRPPPP
   301  GHRVQHQPQK RPPAPSGTQV HQQKGPPLPR PRVQPKPPHG AAENSLSPSS N

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.48
Highest tissue expression
233 nTPM

Expression across tissuesHPA

Tissue

  • thymus: 233 nTPM
  • lymph node: 112 nTPM
  • tonsil: 74 nTPM
  • appendix: 48 nTPM
  • spleen: 42 nTPM
  • small intestine: 27 nTPM

Single-cell type

  • t-cells: 525 nCPM
  • nk-cells: 142 nCPM
  • innate lymphoid cells: 132 nCPM
  • thymocytes: 42 nCPM
  • cdc: 31 nCPM
  • late primary spermatocytes: 22 nCPM

Immune cell

  • NK-cell: 1,111 nTPM
  • memory CD8 T-cell: 714 nTPM
  • T-reg: 657 nTPM
  • memory CD4 T-cell: 612 nTPM
  • total PBMC: 565 nTPM
  • naive CD8 T-cell: 488 nTPM

Brain region

  • medulla oblongata: 2.3 nTPM
  • white matter: 1.5 nTPM
  • thalamus: 1.3 nTPM
  • spinal cord: 1.2 nTPM
  • pons: 1.1 nTPM
  • choroid plexus: 1 nTPM

ReferencesPubMed · IEDB

Publications for CD2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.62
gnomAD pLI
0.47
gnomAD missense Z
0.07
DepMap mean gene effect
-0.11
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CD2 as an antibody target. Whether an autoantibody or antibody against CD2 could matter depends on whether native CD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CD2 is annotated at the cell surface, where native CD2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label CD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CD2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...